Ftse Mib
38.630,54
1,66%
DAX
22.986,82
2,01%
S&P 500
5.629,75
1,96%
NASDAQ
17.726,19
2,45%
Bitcoin
84.754,96
4,59%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Clearmind Medicine Inc (CMND) Clearmind Medicine Inc (CMND) Notizie

Clearmind Medicine Inc

CMND
1,13
0,00 (0,00%)
Ultimo aggiornamento: 19:07:31
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/3/202521:14EDGAR2Form POS AM - Post-Effective amendments for registration..
13/3/202521:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/3/202521:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/3/202512:45GLOBESciSparc-Clearmind Collaboration Leads to Publication of..
10/3/202512:27GLOBEClearmind Medicine Announces Publication of Patent for..
19/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
04/2/202522:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/2/202515:00GLOBESciSparc-Clearmind Collaboration Leads to Publication of..
04/2/202514:35GLOBEClearmind Medicine Announces Publication of Patent for Binge..
22/1/202522:30EDGAR2Form POS AM - Post-Effective amendments for registration..
22/1/202522:15EDGAR2Form 20-F - Annual and transition report of foreign private..
07/1/202522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/1/202515:28GLOBEClearmind Medicine Announces Shareholders Meeting Results
06/1/202522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202514:15GLOBEClearmind Medicine Announces the Publication of European..
06/1/202513:50GLOBESciSparc-Clearmind Medicine Collaboration Announces the..
02/1/202522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202513:45GLOBEClearmind Medicine Granted Patent for Binge Behavior..
26/12/202412:59GLOBEClearmind Medicine Looks to Move Forward with its Novel..
24/12/202412:55GLOBEClearmind Medicine Receives IRB Approval for its..
16/12/202414:37GLOBEClearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet..
09/12/202423:12EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202414:07GLOBEClearmind Medicine Announces IRB Approval for FDA..
26/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202422:30EDGAR2Form POS AM - Post-Effective amendments for registration..
16/9/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202422:06GLOBEClearmind Medicine Announces the Notice of an International..
16/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202414:20GLOBEClearmind Medicine and Yissum File International Patent..
06/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202413:55GLOBEClearmind Medicine Announces Publication of International..
29/8/202422:25GLOBEClearmind Medicine Announces Publication of its Patent..
21/8/202422:11GLOBEClearmind Medicine Granted U.S. Patent Approval for Binge..
16/8/202422:14GLOBEClearmind Medicine and Yissum Expand Collaboration with..
06/8/202414:57GLOBESciSparc’s Collaboration with Clearmind Medicine Continues..
31/7/202413:44GLOBEClearmind Medicine Concludes the Successful Participation in..
19/7/202413:55GLOBEClearmind Medicine Signs an Agreement to Source..
16/7/202415:02GLOBEClearmind Medicine Obtains IND Approval from the FDA to..
16/7/202412:03GLOBEClearmind Medicine Announces Submission of US Patent..
12/7/202414:02GLOBEClearmind Medicine to Present Groundbreaking Research at..
28/6/202413:55GLOBEClearmind Medicine Granted Patent Approval in Hong Kong for..
20/6/202413:57GLOBEClearmind Medicine Secured Exclusive Global Rights to..
13/6/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/6/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/6/202413:44GLOBEClearmind Medicine Revolutionizes the $13 Billion..
10/5/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 1,13 Min: 1,1001 Max: 1,14
Chiusura: 1,13

La tua Cronologia

NASDAQ
CMND
Clearmind Medicine
DOWI
DJUSIP
DJ US Property and Casua...
USOTC
RBZHF
Reebonz (CE)
CSE
CTTT
Critical Infrastructure ...
NYSE
DBRG-H
DigitalBridge
LSE
42RV
Rep.angola 48a
LSE
SN10
Hsbc Bk.27
USOTC
WHTPF
WH Smith (PK)
NASDAQ
UBET
Youbet
COIN
MOGGBP
USOTC
CLLMF
Collective Metals (QB)
USOTC
ANTCF
Aion Therapeutic (PK)
LSE
QUID
Pim Shrt Gbp In
NASDAQ
MRLN
Marlin Business Services
USOTC
CALIQ
China Auto Logistics (CE)
COIN
THOUSD
Athero
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci